Products in brief | Navamedic, Starpharma, Bountiful

Products in brief | Navamedic, Starpharma, Bountiful
A new addition to the Nature's Bounty range targets people suffering from occasional stress

1 July 2021 - Deborah Wilkes

Navamedic has relaunched Angelini Pharma’s ThermaCare, Starpharma has temporarily paused sales of Viraleze in the UK, and The Bountiful Company has extended Nature’s Bounty in the US.

Navamedic relaunches ThermaCare

Navamedic has relaunched Angelini Pharma’s ThermaCare with a new communication concept and new websites in Denmark, Finland, the Netherlands, Norway and Sweden.

Astrid Bratvedt, Navamedic’s chief scientific officer, said the company was highlighting that ThermaCare was an “effective and drug-free” pain relief option.

When Navamedic reported its financial results for the first quarter of 2021, chief executive officer Kathrine Gamborg Andreassen highlighted “rapid growth” of the consumer healthcare products Alflorex and ThermaCare.

Norwegian firm Navamedic announced in April 2020 that it had signed an exclusive distribution agreement for Angelini’s ThermaCare pain-management brand in the Nordic countries and the Netherlands (click here to read the News story).

Italy’s Angelini announced in March 2020 that it had acquired the global business rights to ThermaCare – excluding North America – from GlaxoSmithKline for an undisclosed sum (click here to read the News story).

Starpharma pauses Viraleze sales in the UK

Starpharma and retail partner Lloydspharmacy have temporarily paused sales of the Viraleze antiviral nasal spray in the UK.

The temporary pause in promotion was specific to the UK, said Starpharma, and did not impact other markets where the product was registered for sale including other European countries and India.

The Australian company said Lloydspharmacy had been contacted by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) about “specific promotional claims made for Viraleze”. The claims included references to SARS-CoV-2 and COVID-19, added the company.

Starpharma stressed that the MHRA correspondence did not “question or relate to the safety or quality of Viraleze, but relates to allowable promotional claims”.

“Starpharma, Lloydspharmacy and their expert advisers are engaging with the MHRA to resolve the matter as quickly as possible,” said Starpharma.

Bountiful extends Nature’s Bounty

The Bountiful Company has extended its Nature’s Bounty range of vitamins, minerals and supplements (VMS) in the US with a product for people suffering from occasional stress.

New Stress Comfort Fast Acting Calm carries the on-pack claim “to soothe your mind quickly in response to stress”.

The dietary supplement is supplied as chewable Coolmelts tablets with a “watermelon chill” flavour.

Straplines on the packaging point out the product is “100% drug free”, “non-GMO” and comes “with calming Kanna extract”. Each pack contains 20 tablets.

The Nature’s Bounty brand is set to be acquired by Nestlé. The Swiss food and drinks company recently announced that it had reached an agreement with private-equity firm KKR to acquire The Bountiful Company’s core VMS brands – including Nature’s Bounty and Solgar – for USD5.75 billion (click here to read the News story).

Click tags below for more information on topics:

Navamedic Angelini Starpharma The Bountiful Company

Back to Industry News

Share this page: